The estimated Net Worth of Jonathan Pachter is at least $187 Тысяча dollars as of 13 May 2014. Dr Pachter owns over 1,000 units of Verastem Inc stock worth over $187,474 and over the last 13 years he sold VSTM stock worth over $0.
Sign up
Dr D VSTM stock SEC Form 4 insiders trading
Dr has made over 1 trades of the Verastem Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of VSTM stock worth $7,620 on 13 May 2014.
The largest trade he's ever made was buying 1,000 units of Verastem Inc stock on 13 May 2014 worth over $7,620. On average, Dr trades about 125 units every 0 days since 2012. As of 13 May 2014 he still owns at least 66,955 units of Verastem Inc stock.
You can see the complete history of Dr Pachter stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Jonathan Pachter Ph.D. biography
Dr. Jonathan Pachter Ph.D. is the Chief Scientific Officer at Verastem Inc.
How old is Dr D?
Dr D is 63, he's been the Chief Scientific Officer of Verastem Inc since . There are 3 older and 13 younger executives at Verastem Inc. The oldest executive at Verastem Inc is Timothy Barberich, 72, who is the Independent Director.
What's Dr D's mailing address?
Jonathan's mailing address filed with the SEC is C/O VERASTEM, INC., 215 FIRST STREET, SUITE 440, CAMBRIDGE, MA, 02142.
Insiders trading at Verastem Inc
Over the last 13 years, insiders at Verastem Inc have traded over $5,883,823 worth of Verastem Inc stock and bought 3,873,819 units worth $28,318,633 . The most active insiders traders include Capital Management, L.P.Ra ..., Christoph H Westphal и Ansbert Gadicke. On average, Verastem Inc executives and independent directors trade stock every 28 days with the average trade being worth of $112,479. The most recent stock trade was executed by Dan Paterson on 5 August 2024, trading 3,245 units of VSTM stock currently worth $7,009.
What does Verastem Inc do?
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com
What does Verastem Inc's logo look like?
Complete history of Dr Pachter stock trades at Verastem Inc
Verastem Inc executives and stock owners
Verastem Inc executives and other stock owners filed with the SEC include:
-
Brian Stuglik,
Chief Executive Officer, Director -
Daniel Paterson,
President, Chief Operating Officer -
Robert Gagnon,
Chief Financial Officer, Chief Business Officer -
Brian M. Stuglik BPHARM, R.Ph., RPh,
CEO & Director -
Brian Stuglik R.Ph., RPh,
CEO & Director -
Daniel W. Paterson,
COO & Pres -
Robert E. Gagnon,
Chief Bus. & Financial Officer -
Michael Kauffman,
Lead Independent Director -
Timothy Barberich,
Independent Director -
Eric Rowinsky,
Independent Director -
Alison Lawton,
Independent Director -
Bruce Wendel,
Independent Director -
Gina Consylman,
Independent Director -
John Doyle,
Investor Relations -
Dr. Michelle Dipp M.D., Ph.D.,
Co-Founder -
Sean C. Flynn,
VP, Gen. Counsel & Sec. -
Erin S. Cox,
Sr. Director of Investor Relations & Corp. Communications -
Dr. Jonathan Pachter Ph.D.,
Chief Scientific Officer -
Dr. Michelle Dipp,
Co-Founder -
Dr. Piyush B. Gupta Ph.D.,
Co-Founder -
Dr. Robert A. Weinberg,
nder & Former Chair of Scientific Advisory Board -
Richard H. Aldrich M.B.A., Mba,
Founder and Consultant -
S. Louise Phanstiel,
Director -
Joseph Chiapponi,
Vice President of Finance -
John B Green,
Chief Financial Officer -
Monica Singh,
General Counsel -
Henri A Termeer,
Director -
Stephen A Sherwin,
Director -
Christoph H Westphal,
Executive Chairman -
Paul A Friedman,
Director -
Karin Anna Tollefson,
Director -
Steven H. Bloom,
Chief Strategy Officer -
Julie B Feder,
Chief Financial Officer -
Robert Forrester,
President and CEO -
Ngoc Diep T. Md, Ph D Le,
Chief Medical Officer -
Joseph M Lobacki,
Executive VP & CCO -
Gregory Berk,
Chief Medical Officer -
Capital Investments L.P.Rid...,
-
Capital Management, L.P.Ra ...,
-
John Johnson,
Director -
Management Co. Llc Deer,
Director -
Iii Lp Chp,
10% owner -
John K Clarke,
Director -
Joanna Horobin,
Chief Medical Officer -
Jonathan Pachter,
VP, Head of Research -
Fund, L.P. Longwood,
10% owner -
Venture Partners Vii L.P.Be...,
-
Stephen Kraus,
Director -
Ansbert Gadicke,
Director -
Bioventures V Llcmpm Bioven...,
-
Piyush Gupta,
10% owner -
Iii Lpchp Iii Management, L...,
-
Daniel Calkins,
Chief Financial Officer -
Frank Neumann,
Chief Medical Officer -
Paul A. Bunn,
Director -
Lesley Kim Solomon,
Director -
Michelle Robertson,
Director -
Anil Kapur,
Director -
Dan Paterson,
President and CEO